Arthneeti
Sale is live|00:00:00
Nath Bio-Genes (India) LtdQ1 FY25

Nath Bio-Genes (India) Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 160P/E: 9.6Market Cap: ₹373 CrSector: Agricultural Food & other Products

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

No information is provided regarding the same in the latest conference call.

Margin guidance

No information is provided regarding the same in the latest conference call.

3 more insights locked — sign up free to unlock

Fundraise plans

No information is provided regarding the same in the latest conference call.

Order book

No information is provided regarding the same in the latest conference call.

Capex plans

No information is provided regarding the same in the latest conference call.

How does Nath Bio-Genes (India) Ltd rank vs peers in Agricultural Food & other Products?

Pro feature
1Nath Bio-Genes (India) Ltd

See full Agricultural Food & other Products sector rankings